Compounds of formula I in which R has a meaning as indicated in claim 1, or one of their optical isomers or pharmaceutically acceptable salts, used for the treatment of extrapyramidal movement disorders and/or adverse effects in extrapyramidal movement disorders and/or for the treatment of extrapyramidal symptoms (EPS) induced by neuroleptics.

 
Web www.patentalert.com

< Extraocular device

< Cellulosic-based interference domain for an analyte sensor

> Implantable prismatic device, and related methods and systems

> Pharmaceutical composition containing flavonoids

~ 00295